Among the mutant genes found in MPA samples, 42 have been depicted in the OncoKB database as targetable by known drugs (ALK, 2 drugs; ATM, 1 drug; BRAF, 10 drugs; Breast Cancer Type 2 Susceptibility Protein (BRAC2), 5 drugs; Cyclin Dependent Kinase Inhibitor 2A (CDKN2A), 3 drugs; EGFR, 7 drugs; KRAS, 5 drugs; RAD51 Homolog B (RAD51B), 1 drug). This evidence concerns the gene RAD51B and cancer.